C. Mazurier et al., Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology, BEST P R C, 14(2), 2001, pp. 337-347
Type 2N von Willebrand disease encompasses all patients with factor VIII de
ficiency caused by a markedly decreased affinity of von Willebrand factor f
or factor VIII. It is recessively inherited and clinically similar to mild
haemophilia. The differential biological diagnosis is of major importance f
or providing the optimal treatment and relevant genetic counselling. This a
ccurate diagnosis is based on an evaluation of the factor V111-binding capa
city of plasma von Willebrand factor. Furthermore, molecular biology techni
ques allow the identification of missense mutations in the von Willebrand f
actor gene. All of these induce the substitution of amino acid residues loc
ated in the N terminal part of the mature von Willebrand factor molecule, w
hich contains the factor VIII binding site. Most of them induce a classical
type 2N von Willebrand disease phenotype with factor VIII deficiency but a
normal level and multimeric pattern of von Willebrand factor.